Affiliation:
1. Laboratory of Immunomedicine, Faculty of Medicine, University Complutense of Madrid, Ave Complutense S/N, 28040 Madrid, Spain
Abstract
Regulatory T cells (Tregs) control immune responses and are essential to maintain immune homeostasis and self-tolerance. Hence, it is no coincidence that autoimmune and chronic inflammatory disorders are associated with defects in Tregs. These diseases have currently no cure and are treated with palliative drugs such as immunosuppressant and immunomodulatory agents. Thereby, there is a great interest in developing medical interventions against these diseases based on enhancing Treg cell function and numbers. Here, we give an overview of Treg cell ontogeny and function, paying particular attention to mucosal Tregs. We review some notable approaches to enhance immunomodulation by Tregs with therapeutic purposes including adoptive Treg cell transfer therapy and discuss relevant clinical trials for inflammatory bowel disease. We next introduce ways to expand mucosal Tregs in vivo using microbiota and dietary products that have been the focus of clinical trials in various autoimmune and chronic-inflammatory diseases.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference154 articles.
1. Rezaei, N. (2022). Encyclopedia of Infection and Immunity, Elsevier.
2. Pelaez-Prestel, H.F., Sanchez-Trincado, J.L., Lafuente, E.M., and Reche, P.A. (2021). Immune Tolerance in the Oral Mucosa. Int. J. Mol. Sci., 22.
3. Transitional B cells are the target of negative selection in the B cell compartment;Carsetti;J. Exp. Med.,1995
4. T-cell tolerance: Central and peripheral;Xing;Cold Spring Harb. Perspect. Biol.,2012
5. Mechanisms of unresponsiveness: T- and B-cell mediated mechanisms of anergy;Greenwood;Adv. Exp. Med. Biol.,2001
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献